OBJECTIVES: The purpose of this study was to identify the cut-off value of sarcopenia based on the psoas muscle area index and evaluate early and late outcomes following elective total arch replacement in the elderly.
INTRODUCTION
Sarcopenia, the progressive loss of skeletal muscle size and function associated with aging, was initially reported by Rosenberg [1] . It has been shown to be associated with chronic diseases, such as heart failure, obstructive pulmonary disease, diabetes mellitus, kidney disease, connective tissue disease, tuberculosis infection and wasting conditions [2] . Recently, it has also been linked to surgical outcomes following abdominal operations, including abdominal aortic aneurysm repair [3] .
Historically, sarcopenia has been defined as a muscle mass >2 standard deviations (SDs) below that of healthy adults [4, 5] .
Although the European Working Group on Sarcopenia in Older
People has reported several criteria [6] , the preferred methods for diagnosing sarcopenia remain controversial. Recently, computed tomography (CT) has been identified as one of the most attractive modalities for evaluating skeletal muscle mass, such as of the psoas muscle, for defining sarcopenia [3] ; however, its cutoff value is ambiguous.
The aim of this study was to determine the cut-off levels of sarcopenia based on psoas muscle area index (PAI) and evaluate the impact of sarcopenia on the early and long-term outcomes of elective total arch replacement. In this field, the number of surgical candidates including those who are elderly has been increasing and preoperative risk analysis has become more important because less invasive technique was emerging [7] .
MATERIALS AND METHODS

Patients population
Between August 2010 and August 2015, 1423 patients who underwent CT examination as a part of a trauma screening at Hyogo Emergency Medical Center were enrolled as a control group. To establish the cut-off value of sarcopenia, 464 of the 1423 patients who were between 18 and 39 years old [358 men (77.2%)] were subject to our analysis and provided representative data for healthy adults. In addition, PAI values for all control patients [1033 men, (72.6%)] were also calculated for evaluation by generation (40-49, 50-59, 60-69, 70-79 and > _80 years).
Between October 1999 and July 2015, 374 patients underwent elective total arch replacement for aortic arch aneurysm in our institution; 322 of these were > _65 years old. Fifty-six patients were excluded in whom PAI could not be assessed. Two hundred and sixty-six patients were enrolled in this study.
Follow-up data were obtained by clinical visit, telephone or written correspondence, and were available for all but 5 patients (1.9%), who were lost at hospital discharge and remained without 30-day follow-up. Mean follow-up was 48.3 ± 38.7 months (last follow-up; May 2016).
Image analysis and definition of sarcopenia
Sarcopenia was assessed by measuring the cross sectional area of the right and left psoas muscles. Psoas muscle area was measured at the level of L3 on the first image with both vertebral spines visible. Measurements were performed with manual tracing of psoas muscle borders and setting the density threshold between 30 and 60 Hounsfield units to exclude vasculature and fatty infiltration. The measured psoas area was then normalized for body surface area (BSA) calculated by DuBois The cut-off PAI value for sarcopenia was defined as >2 SDs below the mean PAI for the men and women in the normal control group who were aged between 18 years and 39 years.
Surgical approach
All 266 patients underwent total arch replacement through median sternotomy, and our surgical strategies have evolved, as described in our previous series [8, 9] . Briefly, since 2002, we have exclusively used antegrade selective cerebral perfusion for brain protection, with minimal tympanic temperatures between 20 C and 23 C and minimal rectal temperatures below 30 C. After the distal anastomosis, antegrade perfusion of the lower body and rewarming was started. Subsequently, the proximal anastomosis was performed, followed by coronary reperfusion. Finally, the aortic arch vessels were reconstructed, individually.
Statistical analysis
All continuous variables were expressed as the mean ± SD. A comparison of the clinical characteristics of sarcopenia and nonsarcopenia was performed using the v 2 analysis for categorical variables and the unpaired t-test for continuous variables. Linear trends in the variables across each generation were assessed using the Cochran-Armitage test for categorical variables and the Jonckheere-Terpstra test for continuous variables. P-values <0.05 were considered to be statistically significant. Relationship between continuous variables [total psoas area (TPA) and total psoas volume (TPV); grip strength or gait speed and PAI] was assessed using simple linear regression and R 2 statistics. The values of survival were computed using the Kaplan-Meier technique and expressed as the survival rate ± standard error. Variable with P <0.05 in the univariable analysis was considered to be a candidate for multivariable analysis using the Cox proportional hazards model to compare the difference of survival between sarcopenia and non-sarcopenia in the combined cohort. Comparison of patient survival with the general age-and sex-matched population was done with the Japanese population life table available from Japanese Ministry of Health, Labor and Welfare data [10] according to the methods outlined in Finkelstein et al. [11] . The analysis was performed using JMP 11.0 software (SAS Institute, Cary, NC, USA).
RESULTS
Relationship between muscle area, mass and function
To establish the relationship between the psoas area with the psoas volume, we also measured the total psoas volume using ZIO station 2 by hand tracing the borders of the entire psoas muscle for 266 patients [12] . TPV and TPA were significantly correlated (R 2 = 0.74, P < 0.001) (Fig. 1A ). In addition, in 273 patients who underwent cardiac surgery in our institution between June 2013 and December 2015, hand grip strength and gait speed were significantly correlated with PAI (hand grip: R 2 = 0.42, P < 0.001, and gait speed: R 2 = 0.09, P < 0.001) ( Fig. 1B and C) .
Cut-off psoas muscle area index value for sarcopenia
The average PAI values for men in the normal control group aged 18-39, 40-49, 50-59, 60-69, 70-79 and > _80 years were 11.93 ± 2.52, 10.39 ± 2.48, 9.83 ± 2.28, 9.03 ± 1. 2) . In men, PAI decreased with age (P < 0.001) and in women PAI decreased with age, except for people in their 70s (P < 0.001).
Based on the mean PAI and SDs of younger adults (18-39 years old in the normal control group) for each sex, the cut-off values for sarcopenia were calculated by the equations:
Cut-off value for men : mean PAI-2SDs = 11:93-2 ð2:52Þ The frequency of sarcopenia in the control group for all generation was 0.6% (18-39 years), 6.1% (40-49 years), 8.4% (50-59 years), 11.9% (60-69 years), 16 .5% (70-79 years) and 32.2% (> _80 years), respectively (Fig. 3) . The ratio of sarcopenia increased with age (P<0.001).
Classification of patients
In patients who underwent total arch replacement, mean PAI was 7.70 ± 1.79 cm 2 /m 2 in men and 5.45 ± 1.34 cm 2 /m 2 in women. According to the definition mentioned above, 266 patients were categorized into 2 groups, Group S (patients with sarcopenia) and Group N (patients without sarcopenia). Eighty-one patients (30.5%) were classified into Group S, while 185 patients were classified into Group N.
Early outcomes
Preoperative patient characteristics are shown in Table 1 . The mean age was 76.2 ± 5.6 years in Group S and 75.7 ± 5.7 in Group N (P = 0.553), and Group N contained more women (P = 0.061). Body mass index (P = 0.002) and serum albumin (P = 0.005) were significantly lower in Group S. There were no significant differences in the percentage of comorbidities and risk factors, such as dyslipidaemia, diabetes mellitus, chronic kidney disease (CKD), , respectively. PAI decreased with age for each sex (P < 0.001). Error bar denoted standard deviation. haemodialysis, chronic obstructive pulmonary disease, carotid artery stenosis, coronary artery disease and reoperative surgery, except hypertension (P = 0.023). Although no statistically significant difference was found, Group S included a slightly greater number of high-risk patients for each factor. EuroSCORE II and Japan score for operative mortality were significantly higher in Group S. Preoperative Canadian Study of Health and Aging clinical frailty scale [13] was significantly higher in Group S (S: 3.9 ± 0.9 vs N: 3.5 ± 0.9, P = 0.043).
Intraoperative data and postoperative complications are shown in Table 2 . Cardiopulmonary bypass time, myocardial ischaemia time, circulatory arrest of the lower body and cerebral perfusion time were similar in both groups. Moreover, there were no differences in patients who underwent concomitant procedures. Thirty-day mortality was 1.2% (1 patient) in Group S and 1.1% (2 patients) in Group N (P = 0.914) and hospital mortality was 3.7% (3 patients) in Group S and 2.2% (4 patients) in Group N (P = 0.483). Cause of early death in Group N was multi-system organ failure (n = 2), bowel necrosis (n = 1) and bowel perforation (n = 1), and in Group S was sepsis following pneumonia (n = 2) and haemorrhagic stroke after subsequent thoraco-abdominal aortic replacement (n = 1).
In terms of postoperative complications, patients in Group S had higher risks of renal failure requiring transient or permanent renal replacement therapy compared with Group N (S: 12.3% vs N: 3.2%, P = 0.009). The length of hospital stay was significantly longer in Group S (median, S: 26.0 day vs N: 22.0 day, P = 0.012), while the incidence of other complications was similar between groups.
Late outcomes
During the follow-up period, the total number of late deaths was 44 of 259 hospital survivors, including 9 aortic-related deaths defined as aneurysm rupture (4 patients), consequent aortic operation-related death (2 patients), graft infection (1 patient) and sudden death (2 patients). Patients with sarcopenia experienced significantly worse 5-year survival (S: 63.2 ± 6.6% vs N: 88.7 ± 2.6%, P < 0.001) than patients without sarcopenia (Fig. 4A) . Patients in Group N had relatively better 5-year overall survival compared with that of the entire Japanese population adjusted for age and sex (79.9%). With respect to causes of longterm mortality, freedom from aortic-related death was significantly greater in Group N (S: 87.8 ± 4.6 vs N: 95.9 ± 1.6%, P = 0.014) (Fig. 4B ). The univariable Cox hazard analysis revealed that sarcopenia, age, hypertension, CKD, leukoaraiosis > = moderate [14] , haemoglobin and serum albumin were significant risk factors for overall survival. The multivariable Cox hazard analysis demonstrated that sarcopenia (hazard ratio, 2.59; 95% confidence interval 1.27-5.29, P = 0.011) and CKD (hazard ratio, 2.43; 95% confidence interval 1.08-6.21; P = 0.030) were significant risk predictors of overall survival (Table 3) .
DISCUSSION
Surgical outcomes of total arch replacement have improved over the past decade, even among elderly patients [8, 15, 16] . Our previous study demonstrated that preoperative CKD and chronic obstructive pulmonary disease were negative prognostic factors for patients undergoing elective total arch replacement [17, 18] . Moreover, in an aging society, frailty is a potential novel concept for preoperative risk stratification. Frailty is defined as 'the biologic syndrome that reflects a state of decreased physiological reserve and vulnerability to stressors' [19] . Although some assessments of frailty, such as Katz index, the comprehensive assessment of frailty test and Preoperative Canadian Study of Health and Aging clinical frailty scale were proposed for the Studies of Illness in the Aged [13, 20, 21] , these measurements had several problems from relying on scales dependent on subjective evaluation of weakness, exhaustion and physical activity [22] .
Sarcopenia also includes low-physical function as a component of frailty. Tanimoto et al. [23] demonstrated that decreased muscle mass was significantly associated with instrumental activities of daily living and disability in elderly Japanese. Leong et al. [24] reported in their prospective study that reduction of grip strength was a significant risk factor for cardiovascular death. More recently, assessment of muscle mass on cross-sectional imaging has been reported to be an accurate and quantitative marker. Initially, dual-energy X-ray absorptionmetry and bioelectrical impedance analysis were proposed to evaluate muscle mass using cut-off values 2 SDs below the sex-specific mean of reference values obtained from young adults aged 18-40 years [4, 23, 25] . However, most institutions do not have this equipment. In contrast, grip strength, gait speed and respiratory function tests are less expensive alternatives. There are some limitations of these assessments, in that patients' cooperation is needed. Measurement of muscle mass by CT imaging was helpful as another approach. Moreover, the present study demonstrated that muscle mass was significantly correlated with these physical functional data.
The cut-off value for PAI is still controversial. Most previous reports adopted the lower quartile range, which was not an absolute value but a relative one. Hiraoka et al. [26] proposed a cutoff value for sarcopenia using the psoas muscle area on CT findings of normal Japanese individuals (<55 years, mean age 45 years in 61 men and 47 years in 49 women). However, our study, comprising younger patients aged 18-39 years (mean age, 27 years in men and 28 years in women), with a relatively large number of controls (1033 male patients and 390 female patients), and a single aetiology for trauma screening, is considered to have established more accurate cut-off points.
Moreover, PAI normalized by BSA was more appropriate than was the square of height because TPV had a greater inter-relationship with BSA (R 2 = 0.39, P < 0.001) than with square of height (R 2 = 0.24, P < 0.001). In cardiothoracic surgery, BSA is routinely calculated to estimate cardiac index and is thus, more widely available in the clinical setting. Valero et al. [27] reported that TPV allowed for a more complete assessment of psoas muscle mass than did TPA. Our analysis showed a strong correlation between TPV and TPA (R 2 = 0.74, P < 0.001), demonstrating that TPA might be an attractive alternative measurement that is evaluated more conveniently.
The present study showed that sarcopenia seems to have more prognostic relevance for survival following total arch replacement than age itself, while it did not predict early mortality. Agecategorized subgroup analysis (<75 years and > = 75 years) demonstrated the negative impact of sarcopenia on survival, not only in elderly but also in younger patients (see Supplementary Material, Fig. S1A and S1B ). Four patients in Group S, who refused surgical repair for additional aneurysms due to their deteriorated frailty, died of aneurysm rupture. It might reflect 'the real world'; they could not tolerate total arch replacement from the long-term prospective.
Several studies showed that the same trends were detected in resection of pancreatic cancer, liver tumours and colorectal cancer [3] . Weig et al. [28] reported in lung transplant candidates that psoas muscle mass was inversely associated with respiratory complications and 6-min walking distance. In the field of cardiothoracic surgery, Ganapathi et al. [12] reported that frailty composed of 6 components including TPV was an independent predictor of hospital mortality in proximal aortic surgery. Afilalo et al. [29] reported an adverse relationship with gait speed and early mortality and morbidity following cardiac surgery. Paknikar et al. [30] reported that total psoas area was a simple and reproducible risk assessment tool for identifying optimal strategies for patients undergoing surgical or transcatheter aortic valve replacement.
Limitations
There are several limitations in our study. First, it was retrospective. We did not have the data about other frailty or sarcopenia scales, including the outcomes of quality of life. Second, we used patients undergoing trauma screening as the normal control population. Third, we analysed only an Asian population, and it was not clear whether the same cut-off value could be used for other ethnic groups. Fourth, a computer modelling limitation is that a different software was used to measure PAI in our hospital (ZIO station 2) and Hyogo Emergency Medical Center (PACS). Although other functional or 'eye ball' tests are complementarily important, we believe that sarcopenia evaluated by PAI is helpful in our decision-making. However, further analysis is needed.
CONCLUSIONS
In conclusions, we analysed the PAI of 1423 patients as a normal control group to establish the cut-off value for sarcopenia and the standard value for each generation. According to the cut-off point, we demonstrated the impact of sarcopenia on outcomes following elective total arch replacement in the elderly. Sarcopenia was no predictor of hospital death following total arch replacement, whereas the incidence of prolonged hospital stay and newly renal replacement therapy was higher in patients with sarcopenia. Moreover, sarcopenia was adversely associated with overall survival including freedom from aortic related death. Sarcopenia should be recognized as a new risk predictor for thoracic aortic surgery.
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